CEO WANTED FOR AI-BASED PHARMACEUTICAL START-UP
Our client is a start-up in the field of the application of artificial
intelligence-based knowledge management solutions for pharmaceutical and
biotechnology research and development. The company has an alliance with one
of the leading academic centres of excellence for computer-driven artificial
research in the world.
The company also has highly-experienced sales and technology directors in
place and an impressive list of non-executive directors. The company is now
negotiating with venture funders for funding and with a major pharmaceutical
company to develop and trial the product. We are now looking for a CEO to
complete the management team and to lead the company through the venture
funding, launch and flotation stages.
It is essential that the successful candidate carries credibility within
client organisations in the pharmaceutical and biotechnology sectors. As a
minimum requirement, he or she will have occupied a senior managerial
position, ideally within the pharmaceutical sector. By the nature of both
the industry and the product, the role will call for an individual of the
very highest intellectual calibre.
The CEO will receive an equity stake in the business and a
performance-related option package. The post will be based in the South East
of England. This is a chance to share in the wealth creation process and to
steer an exciting, intellectually-challenging business to flotation.
Please reply in the first instance by email or post with a resume to Emmett
Power, CEO, The MIB Group, 126 Aldersgate Street, London EC1A 4JQ, United
Kingdom, telephone: 0171 687 0352, fax: 0171 687 0358, email:
Emmett at MIB-Group.com.
All applications will be treated in the strictest confidence and will be
used for no other purpose than consideration for the post described above.
**Please excuse any inappropriate or cross-postings**
